Fisher & Paykel’s court proceedings suspended

Company News

by Jessica Amir

The German Court has suspended the patent proceedings against Fisher & Paykel Healthcare (ASX:FPH) due to validity concerns. 

It comes as the healthcare designer and manufacturer had the two patent proceedings put against it by ResMed (ASX:RMD). But the Regional Court in Munich suspended the matters with the final outcome to be filed by the European Patent Office.

The two companies have been in and out of court since May 2017 over validity of patents.

ResMed (ASX:RMD) is however continuing to pursue two other cases, but the Regional Court expressed serious doubts about the claims.

Shares in Fisher & Paykel Healthcare (ASX:FPH) closed 0.26 per cent higher yesterday to $11.66.
 

Jessica Amir

Finance News Network
Jessica joined FNN in January 2017 after having worked in financial advising for seven years and in TV journalism for seven years, specialising in finance, equities and analysis. She has interviewed former Prime Ministers of Australia, Tony Abbott, Julia Gillard and Kevin Rudd and ex Treasurer Jo Hockey. Jessica has worked as a journalist with Sky News Business, ABC 1, ABC's The Business, ABC24 and has also been a regional Channel 7 and 9 TV reporter with Prime7 and Win News.